KOWALIK, MARTA ANNA
 Distribuzione geografica
Continente #
EU - Europa 68.012
NA - Nord America 2.243
AS - Asia 266
AF - Africa 9
SA - Sud America 6
OC - Oceania 3
Totale 70.539
Nazione #
IT - Italia 67.370
US - Stati Uniti d'America 2.227
SE - Svezia 225
CN - Cina 139
UA - Ucraina 137
DE - Germania 94
GB - Regno Unito 55
BE - Belgio 47
FI - Finlandia 39
VN - Vietnam 28
TR - Turchia 27
SG - Singapore 21
FR - Francia 16
IR - Iran 16
CA - Canada 15
IN - India 11
RU - Federazione Russa 8
ZA - Sudafrica 7
TW - Taiwan 5
CH - Svizzera 4
IL - Israele 4
MT - Malta 4
MY - Malesia 4
NL - Olanda 4
AU - Australia 3
IE - Irlanda 3
KR - Corea 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
BR - Brasile 2
CO - Colombia 2
PE - Perù 2
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
ES - Italia 1
GE - Georgia 1
GR - Grecia 1
JP - Giappone 1
LT - Lituania 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
SA - Arabia Saudita 1
Totale 70.539
Città #
Cagliari 67.187
Fairfield 311
Woodbridge 209
Chandler 193
Ashburn 175
Nyköping 175
Houston 154
Ann Arbor 143
Wilmington 113
Seattle 112
Cambridge 102
Dearborn 79
Jacksonville 61
Brussels 47
Boardman 44
Beijing 29
Dong Ket 28
Nanjing 28
Redwood City 22
Helsinki 20
Kocaeli 19
San Mateo 19
New York 18
Boston 17
Milan 15
San Diego 15
Toronto 13
Falls Church 12
Mountain View 11
Jiaxing 10
London 10
Nanchang 10
Rome 10
Shanghai 9
Shenyang 8
Bogazici 7
Changsha 7
Leawood 7
Auburn Hills 6
Augusta 6
Hefei 6
Milwaukee 6
Norwalk 6
Orange 6
Pune 6
Ardabil 5
Atlanta 5
Bari 5
Florence 5
Millbury 5
Phoenix 5
Ploaghe 5
Columbus 4
Guangzhou 4
Hebei 4
Los Angeles 4
Luras 4
Melita 4
Monmouth Junction 4
Monserrato 4
Pretoria 4
Quartu Sant'elena 4
Sassari 4
Verona 4
Zhengzhou 4
Bologna 3
Dublin 3
Durban 3
Jinan 3
Ningbo 3
Selargius 3
Washington 3
Zurich 3
Azzano Decimo 2
Bergamo 2
Bogotá 2
Chicago 2
Chiswick 2
Clauzetto 2
Kilburn 2
Kunming 2
Lerici 2
Lima 2
Nuoro 2
Palermo 2
Paris 2
Quarrata 2
Saint-Fons 2
Salvador 2
Southwark 2
Suri 2
Taipei 2
Tehran 2
Tianjin 2
Trento 2
Wuhan 2
Acton 1
Alghero 1
Amsterdam 1
Andover 1
Totale 69.652
Nome #
Thyroid hormone receptor ligands induce regression of rat preneoplastic liver lesions causing their reversion to a differentiated phenotype 3.878
Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats 3.535
Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats 3.395
Statistical health monitoring applied to a metabolomic study of experimental hepatocarcinogenesis: an alternative approach to supervised methods for the identification of false positives 3.353
Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis 3.337
TRbeta is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells 3.318
Expression of c-jun is not mandatory for mouse hepatocyte proliferation induced by two nuclear receptor ligands: TCPOBOP and T3 3.316
Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice 3.298
YAP activation is an early event and a potential therapeutic target in liver cancer development 3.233
Global gene expression profile of normal and regenerating liver in young and old mice 3.164
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis 2.867
Transcription profiling by array of mouse liver from TCPOBOP treated wild type and c-jun conditional knockout animals. 2.798
Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis 2.773
Induction of autophagy promotes the growth of early preneoplastic rat liver nodules 2.732
MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC). 2.715
Reply to: "YAP in tumorigenesis: Friend or foe?" 2.519
Emerging role of the pentose phosphate pathway in hepatocellular carcinoma 2.204
High frequency of β-catenin mutations in mouse hepatocellular carcinomas induced by a nongenotoxic constitutive androstane receptor agonist 2.184
Reply to: Clinical correlation of miR-375 and alpha-fetoprotein in hepatocellular carcinoma: comparison in mice and humans 2.084
Thyroid hormones, thyromimetics and their metabolites in the treatment of liver disease 1.980
Gender-specific interplay of signaling through β-catenin and CAR in the regulation of xenobiotic-induced hepatocyte proliferation 1.672
Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience 1.508
Early metabolic changes in a liver carcinogenesis model 1.010
Early Metabolic Changes in preneoplastc nodules of the liver 841
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming 708
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection 693
Animal models: A useful tool to unveil metabolic changes in hepatocellular carcinoma 621
Effect of the ligands of thyroid hormone receptor on non-alcoholic fatty liver disease 609
Potential role of two novel agonists of thyroid hormone receptor-β on liver regeneration 606
Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis 576
Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC 509
Tg68, a novel thyroid hormone receptor‐β agonist for the treatment of NAFLD 355
mRNA-miRNA networks identify metabolic pathways associated to the anti-tumorigenic effect of thyroid hormone on preneoplastic nodules and hepatocellular carcinoma 279
Characterization Of Early Stage Metabolic Perturbations In A Rat Model Of Hepatocellular Carcinogenesis 221
The double-sided of human leukocyte antigen-G molecules in type 1 autoimmune hepatitis 204
Diverse MicroRNAs-mRNA networks regulate the priming phase of mouse liver regeneration and of direct hyperplasia 196
Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis 177
Delta-globin gene expression improves sickle cell disease in a humanised mouse model 173
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 165
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 159
Novel thyroid hormone receptor beta agonist TG68 safely induces hepatic fat loss reduction in a NASH mouse model 157
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 154
THYROID HORMONE INHIBITS HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT BY INTERFERING WITH THE METABOLIC PROFILE OF CANCER CELLS 145
The density of hepatic autonomic innervation differs between compensatory and direct hyperplasia rat models 128
Multi-Organ Morphological Findings in a Humanized Murine Model of Sickle Cell Trait 90
Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis 30
Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma 24
Totale 70.693
Categoria #
all - tutte 80.483
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.483


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.149 0 0 0 0 0 0 0 235 191 181 336 206
2019/202014.442 590 507 51 129 5.221 3.742 1.983 450 262 355 386 766
2020/202118.781 532 816 733 5.573 3.262 2.004 1.248 1.166 596 1.123 1.138 590
2021/20225.241 755 347 229 341 512 363 208 190 536 571 598 591
2022/20237.849 448 870 1.016 693 625 876 509 457 520 648 781 406
2023/20245.028 477 249 275 387 727 1.152 1.307 454 0 0 0 0
Totale 70.693